Testing the role of unstimulated ın vitro maturation in the developmental potential of immature oocytes in women with oocyte maturation abnormalities.

Şenol KalyoncuAlper BaşbuğEbru HatırnazAşkı Ellibeş KayaNur Dokuzeylül GüngörSebati Sinan ÜrkmezYeşim Civil ÜrkmezŞafak Hatırnaz

Published in: Journal of the Turkish German Gynecological Association (2024)

Unstimulated non hCG primed IVM has no value in the treatment of OMAS, except in cases with resistant ovary syndrome. However this study led our team to develop novel treatment options based on physiological mechanisms for some subtypes and supraphysiological approach for other subtypes of oocyte maturation abnormalities.

Keyphrases

palliative care
quality improvement
combination therapy
risk assessment